BlackRock Advisors’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$252K Sell
20,800
-444
-2% -$5.38K ﹤0.01% 2529
2016
Q3
$209K Buy
21,244
+2,365
+13% +$23.3K ﹤0.01% 2607
2016
Q2
$193K Sell
18,879
-58
-0.3% -$593 ﹤0.01% 2583
2016
Q1
$230K Buy
18,937
+7,169
+61% +$87.1K ﹤0.01% 2447
2015
Q4
$189K Sell
11,768
-5,667
-33% -$91K ﹤0.01% 2564
2015
Q3
$224K Sell
17,435
-349
-2% -$4.48K ﹤0.01% 2626
2015
Q2
$427K Sell
17,784
-32,895
-65% -$790K ﹤0.01% 2266
2015
Q1
$952K Buy
50,679
+11,663
+30% +$219K ﹤0.01% 1563
2014
Q4
$736K Buy
39,016
+32,504
+499% +$613K ﹤0.01% 1679
2014
Q3
$177K Sell
6,512
-409,104
-98% -$11.1M ﹤0.01% 2663
2014
Q2
$12.9M Buy
415,616
+15,461
+4% +$481K 0.01% 692
2014
Q1
$9.11M Buy
400,155
+397,246
+13,656% +$9.04M 0.01% 805
2013
Q4
$61K Sell
2,909
-57,136
-95% -$1.2M ﹤0.01% 3176
2013
Q3
$2.4M Buy
60,045
+57,226
+2,030% +$2.29M ﹤0.01% 1112
2013
Q2
$79K Buy
+2,819
New +$79K ﹤0.01% 3020